STOK
Stoke Therapeutics Inc
24.70$
+3.3%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +7.7% | -10.1% | +12.5% | +57.6% | -148.2% | – | -15.3% | +50.5% | +14.6% | +1.3% | +362.1% | +601.2% | -91.3% | -23.1% | -86.8% | +344.3% | +49.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +3.7% | +9.5% | +7.8% | +0.5% | +33.8% | +10.7% | +24.7% | -0.4% | +1.7% | +2.8% | +1.2% | -8.4% | -0.3% | +0.1% | -0.3% | -2.9% | -1.7% | -6.5% | +6.7% | -0.8% | +8.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.8% | -17.3% | +6.9% | +89.2% | -191.1% | – | -24.7% | +95.5% | +19.9% | +31.5% | +362.1% | +601.2% | -91.3% | -30.2% | -96.4% | +1,393.4% | +58.0% | – | |
| – | +50.8% | +18.0% | +34.9% | +37.6% | +45.7% | +8.2% | +8.8% | +1.8% | +10.4% | +1.8% | +9.8% | +11.3% | +42.2% | +1.9% | +10.1% | +14.3% | 0.0% | +9.2% | +3.7% | -6.9% | +4.8% | -1.5% | +7.7% | +3.1% | -5.6% | +7.9% | +5.5% | +39.5% | -20.9% | +44.1% | +10.8% | -3.9% | +23.6% | – | |
| – | +70.0% | -2.9% | +41.1% | +42.3% | +10.6% | +37.2% | +19.7% | +13.6% | +11.6% | +11.1% | +1.4% | +21.7% | +14.8% | +4.9% | +4.8% | +8.7% | +6.6% | -1.7% | -5.6% | +8.8% | +0.2% | +0.4% | +3.3% | -3.7% | +27.6% | -2.6% | +1.2% | +14.1% | +4.2% | +5.0% | +31.9% | -5.5% | +26.4% | – | |
| – | +57.4% | +10.2% | +36.9% | +39.2% | +33.6% | +16.5% | +12.5% | +6.0% | +10.9% | +5.4% | +6.4% | +15.4% | +30.9% | +3.0% | +8.1% | +10.8% | +1.7% | +5.4% | +0.6% | -2.0% | +3.2% | -0.9% | +6.2% | +1.0% | +5.0% | +5.5% | +3.9% | +30.5% | -13.1% | +28.3% | +17.2% | -5.2% | +25.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -124.5% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | +9.1% | – | – | +183.3% | +29.4% | +77.3% | +33.3% | +423.1% | +82.9% | +48.6% | +42.2% | +22.1% | +3.3% | -2.4% | -6.2% | +52.3% | -4.1% | – | – | +200.0% | +0.0% | +0.0% | +666.7% | -26.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -120.6% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -90.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -120.8% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -120.1% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.